125 filings
Page 4 of 7
8-K
4u5alghb7c 2str60y92
24 Jul 19
Entry into a Material Definitive Agreement
4:48pm
8-K
hi4uel
22 Jul 19
Salarius Pharmaceuticals Announces Closing of Strategic Merger
5:08pm
8-K
c7stppzi
15 Jul 19
Submission of Matters to a Vote of Security Holders
4:18pm
8-K
yexcz qtc1dpo
1 Jul 19
Entry into a Material Definitive Agreement
3:03pm
8-K
0n9nl z41s2
14 Jun 19
Submission of Matters to a Vote of Security Holders
5:25pm
8-K
0z7t 4yi7a2y5nwq1ic
1 May 19
Flex Pharma Reports First Quarter 2019 Financial Results
7:32am
8-K
q5eyyhr
6 Mar 19
Flex Pharma Reports Fourth Quarter and Fiscal 2018 Financial Results
7:26am
8-K
8k7v5 n2g
15 Feb 19
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:27pm
8-K
8kdpa5p 9j90chi
4 Jan 19
Flex Pharma and Salarius Pharmaceuticals Announce Merger Agreement to Accelerate Clinical Development of Novel Epigenetic Therapy for Cancer
9:04am
8-K
cdvv6wymt 1p1d0k
28 Nov 18
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
7:58am
8-K
hzyccdfn nygcvn9d
5 Nov 18
Flex Pharma Reports Third Quarter 2018 Financial Results
8:00am
8-K
vo6t2 sxgxzbmnr
1 Oct 18
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:06pm
8-K
1ojpt
15 Aug 18
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
8:32am
8-K
ix3cfnrgibg0fzh5gk9l
1 Aug 18
Flex Pharma Reports Second Quarter 2018 Financial Results
8:10am
8-K
eapmwv2x5ejn0482sck0
25 Jul 18
Departure of Directors or Certain Officers
4:11pm
8-K/A
32tgr4a
20 Jun 18
Cost Associated with Exit or Disposal Activities
4:16pm
8-K
0f72i60e13q
13 Jun 18
Cost Associated with Exit or Disposal Activities
12:00am
8-K
q15o9bm nfuwovoesls
8 Jun 18
Submission of Matters to a Vote of Security Holders
4:33pm
8-K
zvmzkn308e69xzjqoqyg
2 May 18
Flex Pharma Reports First Quarter 2018 Financial Results
8:33am
8-K
zdtuj jqx173s5w
26 Mar 18
Flex Pharma Reports Positive Topline Data from Exploratory Phase 2 Trial of FLX-787 in Multiple Sclerosis
12:00am